Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

EBITDA Margin

33.72%

TTM · Period ending: Jun 30, 2026

AZN EBITDA Margin

Latest reported33.72%period endingJun 30, 2026

Latest reported33.72%period endingJun 30, 2026

AZN TTM EBITDA Margin (17.34% → 33.72%)

TTM ebitda margin

High-resolution chart · PNG

AZN ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares EBITDA Margin — Trailing twelve months (TTM)
Period ending	EBITDA Margin
Jun 30, 2001	26.9143%
Mar 31, 2001	27.5733%
Dec 31, 2000	27.1086%
Sep 30, 2000	18.1216%
Jun 30, 2000	17.4873%
Mar 31, 2000	17.1162%
Dec 31, 1999	34.579%
Sep 30, 1999	10.1366%
Jun 30, 1999	20.3831%
Mar 31, 1999	19.3042%
Dec 31, 1998	2.0245%
Sep 30, 1998	11.7966%
Jun 30, 1998	9.76%
Mar 31, 1998	26.3017%
Dec 31, 1997	25.2031%
Sep 30, 1997	34.0292%
Jun 30, 1997	35.2645%
Mar 31, 1997	35.2334%
Dec 31, 1996	35.2022%
Sep 30, 1996	24.5304%
Jun 30, 1996	21.0693%
Mar 31, 1996	-2.0066%
Dec 31, 1995	-5.4549%
Sep 30, 1995	3.8603%
Jun 30, 1995	1.5596%
Mar 31, 1995	21.213%
Dec 31, 1994	19.2545%
Sep 30, 1994	22.0025%
Jun 30, 1994	19.5068%
Mar 31, 1994	18.4389%
Dec 31, 1993	17.3423%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.